BioNTech GAAP EPS of -€1.60, revenue of €260.8M Posted on August 4, 2025 by wpadmin BioNTech press release (NASDAQ:BNTX): Q2 GAAP EPS of -€1.60. Revenue of €260.8M (+102.6% Y/Y). Revenues for the 2025 financial year €1,700 million – €2,200 million More on BioNTech BioNTech: More Uncertainty Emerges BioNTech’s Acquisition Of CureVac Brings Complementary Method To Target Cancer Bristol-Myers And BioNTech Deal: Good For Both Parties, But One Is The Better Investment BioNTech Q2 2025 Earnings Preview Experts helping vaccine advisors are reportedly ousted at CDC